Neuberger High Yield Strategies Fund Inc. (NHS) Stock
The Neuberger High Yield Strategies Fund Inc., identified by its symbol NHS, is a closed-end investment vehicle focused on fixed income. Established by Neuberger Berman LLC and overseen by Neuberger Berman Investment Advisers LLC, it allocates capital to debt instruments in global markets.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About Neuberger High Yield Strategies Fund Inc.
The Neuberger High Yield Strategies Fund Inc., identified by its symbol NHS, is a closed-end investment vehicle focused on fixed income. Established by Neuberger Berman LLC and overseen by Neuberger Berman Investment Advisers LLC, it allocates capital to debt instruments in global markets. The fund primarily targets high-yield bonds issued by companies across numerous sectors, such as automotive components and equipment, airlines, the broader automotive industry, electronics, healthcare services, packaging, integrated and service-based telecommunications, gaming, and natural gas distribution. Formed on July 28, 2003, and based in the United States, it was previously known as the Neuberger Berman High Yield Strategies Fund.
Neuberger High Yield Strategies Fund Inc. is headquartered in US.
Neuberger High Yield Strategies Fund Inc. (NHS) stock trades at $6.08 with a market capitalization of $190.67M. The stock is valued at a price-to-earnings (P/E) ratio of 10.13, price-to-book of 1.71, price-to-sales of 7.36. Over the past 52 weeks the stock has ranged between $5.97 and $7.75, and currently trades 21.5% below its 52-week high. It pays a dividend yielding 17.93%.
On profitability, Neuberger High Yield Strategies Fund Inc. generates a return on equity (ROE) of 8.07%, return on capital employed of 6.29%, an operating margin of 101.87%, a net profit margin of 80.75%.
Official website: www.nb.com/Pages/Public/en-us/Products/high-yield-strategies-fund.aspx